31 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Lowsky, Hematologist in Stanford, CA?
Dr. Robert Lowsky, MD is a Hematologist, who primarily practices in Stanford, CA with 1 additional practice location. He has been practicing for over 31 years and is board certified by the American Board of Internal Medicine. Dr. Lowsky graduated from McGill University Faculty of Medicine and completed his residency at Toronto General Hospital, Canada. Dr. Lowsky is fluent in English and French, and is currently seeing new patients. Dr. Lowsky’s practice accepts Kaiser Permanente, Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Lowsky’s office at (650) 723-4000.
Where did Dr. Lowsky go to medical school and complete their residency?
Fellowship: Toronto General Hospital, Canada | Toronto General Hospital, Canada
Residency: Toronto General Hospital, Canada | Toronto General Hospital
Medical School: McGill University Faculty of Medicine
Is Dr. Lowsky board certified in Hematologist?
Yes, Dr. Robert Lowsky, MD is board certified by the American Board of Internal Medicine since 1992
What languages does Dr. Lowsky speak?
Dr. Lowsky and their clinical team can communicate with patients in the following languages:
English
French
What conditions does Dr. Lowsky treat?
As a Hematologist, Dr. Lowsky diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Lowsky. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Acute Myeloid Leukemia in Remission
- Acute Myeloid Leukemia
- Acute Lymphocytic Leukemia in Remission
- Acute Lymphoblastic Leukemia
- Chronic Myeloid Leukemia
- Chronic Myelomonocytic Leukemia
- Acute Myeloid Leukemia in Relapse
- Acute Lymphocytic Leukemia
- Chronic Myelogenous Leukemia Treatment (PDQ®)
- Myelodysplastic/Myeloproliferative Neoplasms Treatment (PDQ®)
- AML Leukemia in Remission
- Acute Myeloblastic Leukemia in Remission
- Acute Myelogenous Leukemia in Remission
- AML Leukemia
- Acute Myeloblastic Leukemia
- Acute Myelogenous Leukemia
- ALL Leukemia in Remission
- Acute Lymphoblastic Leukemia in Remission
- Childhood Leukemia in Remission
- ALL
- Acute lymphocytic leukemia
- Lymphoblastic leukemia
- CML
- Chronic myelogenous leukemia
- Philadelphia chromosome positive leukemia
- CMML
- Myelomonocytic Leukemia
- AML Leukemia in Relapse
- Acute Myeloblastic Leukemia in Relapse
- Acute Myelogenous Leukemia in Relapse
ICD-10 Codes:
- C9201: Acute myeloblastic leukemia, in remission
- C9200: Acute myeloblastic leukemia, not having achieved remission
- C9101: Acute lymphoblastic leukemia, in remission
- C9100: Acute lymphoblastic leukemia not having achieved remission
- C9210: Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
- C9310: Chronic myelomonocytic leukemia not having achieved remission
- C9202: Acute myeloblastic leukemia, in relapse
Also known as:
- Bone Marrow Transplant
- Bone Marrow Transplantation
- Stem Cell Transplant
- Hematopoietic Stem Cell Transplant
- Marrow Transplant
ICD-10 Codes:
- Z9481: Bone marrow transplant status
Also known as:
- Multiple Myeloma
- Multiple Myeloma in Remission
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ)
- Active multiple myeloma
- Untreated multiple myeloma
- Plasma cell myeloma
- Plasma Cell Myeloma in Remission', 'Kahler's Disease in Remission
- Myeloma in Remission
ICD-10 Codes:
- C9000: Multiple myeloma not having achieved remission
- C9001: Multiple myeloma in remission
Also known as:
- Myelodysplastic Syndrome
- Myelodysplastic Syndromes
- Myelodysplastic Syndromes Treatment (PDQ®)
- Myelodysplastic Syndromes Treatment (PDQ)
- MDS
- Preleukemia
- Bone marrow failure disorder
- Bone Marrow Failure Syndrome
ICD-10 Codes:
- D469: Myelodysplastic syndrome, unspecified
- D46Z: Other myelodysplastic syndromes
Also known as:
- Myelofibrosis
- Chronic Myeloproliferative Neoplasm
- Bone Marrow Disease
- Chronic Myeloproliferative Neoplasms Treatment (PDQ®)
- Primary myelofibrosis
- Chronic idiopathic myelofibrosis
- Bone marrow scarring
- CMPN
- Myeloproliferative disorder
- Chronic blood cancer
ICD-10 Codes:
- D474: Osteomyelofibrosis
- D471: Chronic myeloproliferative disease
Also known as:
- Stem Cell Donation
- Stem Cells
- Donate stem cells
- Bone marrow donation
- Hematopoietic stem cell donation
ICD-10 Codes:
- Z52001: Unspecified donor, stem cells
Also known as:
- Aplastic Anemia
- Bone Marrow Failure Anemia
- Marrow Aplasia
ICD-10 Codes:
- D619: Aplastic anemia, unspecified
Also known as:
- Diffuse Large B-cell Lymphoma
- Lymphoma
- DLBCL
- Aggressive B-cell Lymphoma
- Diffuse B-cell Lymphoma
ICD-10 Codes:
- C8330: Diffuse large B-cell lymphoma, unspecified site
Also known as:
- Myelofibrosis
- Bone Marrow Disease
- Bone Marrow Scarring
- Primary Myelofibrosis
ICD-10 Codes:
- D7581: Myelofibrosis
Also known as:
- Multiple Sclerosis
- MS
- Demyelinating Disease
ICD-10 Codes:
- G35: Multiple sclerosis
Which procedures does Dr. Lowsky perform as a Hematologist?
As a Hematologist, procedures performed by a Dr. Robert Lowsky may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Lowsky's office.
Does Dr. Lowsky accept my insurance?
Dr. Lowsky accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Lowsky accept in Stanford, CA?
Dr. Lowsky in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Express Scripts
Kaiser Permanente
Medicaid
Medicare
OptumRx
Santa Clara Family Health Plan
State of California
UnitedHealthcare
Valley Health Plan
View All Insurances
Where is Dr. Lowsky's office located?
Recognitions
Publications
Tolerance and Withdrawal of Immunosuppressive Drugs
AMERICAN JOURL OF TRANSPLANTATION, 2012
Translatiol studies in hematopoietic cell transplantation
SEMIRS IN IMMUNOLOGY, 2011
Long-term outcomes in patients with high
BONE MARROW TRANSPLANTATION, 2011
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular
BRITISH JOURL OF HAEMATOLOGY, 2010
NKT cells, Treg, and their interactions in bone marrow transplantation
EUROPEAN JOURL OF IMMUNOLOGY, 2010
Tolerance and chimerism after rel and hematopoietic-cell transplantation.
New England jourl of medicine, 2008
RIZ1 repression is associated with insulin-like growth factor
ONCOGENE, 2007
Protective conditioning for acute graft-versus-host disease
NEW ENGLAND JOURL OF MEDICINE, 2005
A technique of bone marrow collection from vertebral bodies of cynomolgus macaques
JOURL OF SURGICAL RESEARCH, 2005
Short tandem repeat alysis to monitor chimerism in Macaca fascicularis
AMERICAN JOURL OF TRANSPLANTATION, 2004
Bronchiolitis obliterans organizing pneumonia
EUROPEAN JOURL OF HAEMATOLOGY, 2001
Total lymphoid irradiation-antithymocyte globulin conditioning
Biology of blood and marrow transplantation, 2014
Identification of gene microarray expression profiles in patients with chronic graft-versus
Clinical immunology, 2013
Prophylactic rituximab after allogeneic transplantation decreases B
BLOOD, 2012
Rare cells predict GVHD.
Blood, 2012
Tolerance and Withdrawal of Immunosuppressive Drugs
AMERICAN JOURNAL OF TRANSPLANTATION, 2012
Tandem chemo-mobilization followed by high
BONE MARROW TRANSPLANTATION, 2012
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative
BONE MARROW TRANSPLANTATION, 2012
Donor immunization with WT1 peptide augments antileukemic activity after MHC
BLOOD, 2011
Adoptive Immunotherapy with Cytokine
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011
Translational studies in hematopoietic cell transplantation
SEMINARS IN IMMUNOLOGY, 2011
Long-term outcomes in patients with high
BONE MARROW TRANSPLANTATION, 2011
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular
BRITISH JOURNAL OF HAEMATOLOGY, 2010
Phase I/II Trial of GN-BVC
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010
NKT cells, Treg, and their interactions in bone marrow transplantation
EUROPEAN JOURNAL OF IMMUNOLOGY, 2010
Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged
BONE MARROW TRANSPLANTATION, 2010
Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update
CURRENT OPINION IN HEMATOLOGY, 2009
TLI and ATG conditioning with low risk of graft-versus
BLOOD, 2009
Total lymphoid irradiation for graft-versus-host disease protection.
Current opinion in oncology, 2009
Tolerance and chimerism after renal and hematopoietic-cell transplantation.
New England journal of medicine, 2008
Thymoglobulin and regulatory T cells in organ and hematopoietic cell transplantation
TRANSPLANTATION, 2007
RIZ1 repression is associated with insulin-like growth factor
ONCOGENE, 2007
High-dose carmustine, etoposide
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006
Total lymphoid irradiation and transplantation tolerance
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2006
Protective conditioning for acute graft-versus-host disease
NEW ENGLAND JOURNAL OF MEDICINE, 2005
A technique of bone marrow collection from vertebral bodies of cynomolgus macaques
JOURNAL OF SURGICAL RESEARCH, 2005
Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell
BLOOD, 2005
CD34, CD49 and CD8 cell doses do not influence engraftment
EXPERIMENTAL HEMATOLOGY, 2005
Short tandem repeat analysis to monitor chimerism in Macaca fascicularis
AMERICAN JOURNAL OF TRANSPLANTATION, 2004
Approaches to transplantation tolerance in humans
TRANSPLANTATION, 2004
Bronchiolitis obliterans organizing pneumonia
EUROPEAN JOURNAL OF HAEMATOLOGY, 2001
What is Dr. Lowsky's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Lowsky's National Provider Identifier (NPI) number is 1083756308.
What common questions do patients ask about Dr. Lowsky?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Lowsky
What is Dr. Robert Lowsky's specialty?
Dr. Lowsky is a Hematologist near Stanford, CA. An internist with advanced training specializing in disorders of the blood, spleen, and lymphatic system. This specialist manages conditions such as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia, and lymphoma. Contact Dr. Lowsky to book an appointment today.
Is this Dr. Robert Lowsky affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Lowsky is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Hematologist?
Explore Hematologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Robert Lowsky accepting new patients in Stanford, CA?
Yes, Dr. Robert Lowsky is accepting new patients at this time.
Does Dr. Robert Lowsky offer online booking?
Please contact Dr. Lowsky's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Robert Lowsky?
Please contact Dr. Lowsky's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Robert Lowsky have?
Dr. Robert Lowsky is certified by the American Board of Internal Medicine.
Other Hematologist Near Stanford, CA
Hematologist
Accepting patientsHematologist
Accepting patientsMedical Oncologist
Accepting patients